A61P

Therapeutic Activity

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

97 items

(filtered)
Publication

Inhibiting Purine Biosynthesis To Increase Favipiravir Potency Against Rna Virus Infections

EP4525915A2 · VIRIOM, Inc. · Mar 18, 2026
Publication

Indolizine Compounds For The Treatment Of Mental Disorders Or Inflammation

EP4499058A2 · Tactogen Inc. · Mar 18, 2026
Publication

Abietanes And Methods Of Making And Using The Same

EP4499055A2 · The Florida State University Research Foundation, Incorporated · Mar 18, 2026
Publication

Methods And Compositions For Modulating Kras(g12 D)

EP2024044334A2 · Ranok Therapeutics (Hangzhou) Co. Ltd. · Mar 18, 2026
Publication

Organic Compounds

EP4493559A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Organic Compounds

EP4493560A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Lrrk2 Inhibitors

EP4504722A2 · Brenig Therapeutics, Inc. · Mar 18, 2026
Publication

Liquid Dispersible Halopyruvate Formulations And Associated Methods

EP4504152A2 · Ko, Young Hee · Mar 18, 2026
Publication

Combination Therapies Comprising A Sos1 Inhibitor And A Mek Inhibitor

EP4504197A2 · Mirati Therapeutics, Inc. · Mar 18, 2026
Publication

Combination Therapies Comprising A Sos1 Inhibitor And An Egfr Inhibitor

EP4504171A2 · Mirati Therapeutics, Inc. · Mar 18, 2026
Publication

Methods Of Selecting And Treating Cancer Subjects That Are Candidates For Treatment Using Inhibitors Of Parp

EP4496904A2 · Arima Genomics, Inc. · Mar 18, 2026
Publication

Multiplex Gene Edited Cells For Cd70 Directed Cancer Immunotherapy

EP4482872A2 · Nkarta, Inc. · Mar 18, 2026
Publication

Non Aromatic Cyclic Pyrimidine Analogs As Glucosylceramide Synthase Inhibitors

EP4490148A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Regulatory T Cells With Chimeric Antigen Receptor Targeting Co Stimulatory Molecules To Prevent And/Or Treat Inflammatory Conditions

EP4486764A2 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Virus Like Particles Displaying Sars Cov 2 Antigens As Booster Vaccines And Uses Thereof

EP4593874A2 · Bavarian Nordic A/S · Mar 18, 2026
Publication

Vectors Combining Anti Sickling Beta As3 Globin With Anti Bcel11 A Sh Rna Mir To Treat Beta Hemoglobinopathies

EP4490302A2 · The Regents of University of California · Mar 18, 2026
Publication

Methods And Compositions For The Treatment Of Alcohol Toxicity

EP4489857A2 · The Board of Regents of the University of Texas System · Mar 18, 2026
Publication

Compositions And Methods For Cancer Immunotherapy

EP4475865A2 · Mural Oncology, Inc. · Mar 18, 2026
Publication

Multispecific Binding Agents And Uses Thereof

EP4475886A2 · Exelixis, Inc. · Mar 18, 2026
Publication

Production Of Rna Polynucleotides Encoding Picornavirus

EP4514822A2 · ElevateBio Technologies, Inc. · Mar 18, 2026
Publication

Hypoimmune Beta Cells Differentiated From Pluripotent Stem Cells And Related Uses And Methods

EP4463171A2 · Sana Biotechnology, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4472967A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Vaccine Against Leptospirosis

EP4469470A2 · Yale University · Mar 18, 2026
Publication

Compositions, Devices And Methods For Treating Cns Disorders

EP4469490A2 · Sigilon Therapeutics, Inc. · Mar 18, 2026
Publication

Use Of Myostatin Inhibitor For Treating Spinal Muscular Atrophy

EP4518970A2 · Scholar Rock, Inc. · Mar 18, 2026
Publication

Vectorized Anti Complement Antibodies And Complement Agents And Administration Thereof

EP4518972A2 · RegenxBio Inc. · Mar 18, 2026
Publication

Allogeneic T Cells For Treatment Of Hematological Malignancies

EP4511056A2 · Bluesphere Bio, Inc. · Mar 18, 2026
Publication

Solid Forms Of Ceftolozane

EP4327828A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Anticonvulsant Activity Of Steroids

EP4335505A2 · The Regents of the University of California · Mar 18, 2026
Publication

Pharmaceutical Composition Containing A Surfactant And Natural Plant Extracts For Preventing And Treating Coronavirus

EP4299132A2 · Portillo Rosado, Rosa Maria · Mar 18, 2026
Publication

Use Of The Cd2 Signaling Domain In Second Generation Chimeric Antigen Receptors

EP4275699A2 · The Trustees of the University of Pennsylvania · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Muscle Atrophy Comprising Glucagon Like Peptide 1 Receptor Agonist

EP4272823A2 · Immunoforge Co., Ltd. · Mar 18, 2026
Publication

A Method For Morselizing And/Or Targeting Pharmaceutically Active Principles To Synovial Tissue

EP4374861A2 · MedinCell S.A. · Mar 18, 2026
Publication

Crystalline Forms Of N (4 (4 (Cyclopropylmethyl) Piperazine 1 Carbonyl)phenyl)quinoline 8 Sulfonamide

EP4285904A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248967A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248966A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

A Pyrazole Pharmaceutical Composition

EP4282475A2 · Intervet International B.V. · Mar 18, 2026
Publication

Menotropin For Treating Infertility

EP4289477A2 · Ferring B.V. · Mar 18, 2026
Publication

Crystalline Forms Of (2 R,5 S,13 Ar) 8 Hydroxy 7,9 Dioxo N (2,4,6 Trifluorobenzyl) 2,3,4,5,7,9,13,13 A Octahydro 2,5 Methanopyrido [1',2':4,5]Pyrazino [2,1 B][1,3]Oxazepine 10 Carboxamide

EP4309736A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Formulations Of Guanylate Cyclase C Agonists And Methods Of Use

EP4309673A2 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Compound For Use In Methods For Treatment Of Polycystic Kidney Disease

EP4268891A2 · Regulus Therapeutics Inc. · Mar 18, 2026
Publication

Peptide Having Effects Of Increasing Telomerase Activity And Extending Telomere, And Composition Containing Same

EP4272829A2 · Gemvax & Kael Co., Ltd. · Mar 18, 2026
Publication

Process For The Preparation Of Erythrocytes Loaded With One Or More Substances Of Pharmaceutical Interest And So Obtained Erythrocytes

EP4338803A2 · Quince Therapeutics, Inc. · Mar 18, 2026
Publication

Alkyl Chain Modified Imidazoquinoline Derivatives As Tlr7/8 Agonists And Uses Thereof

EP4257198A2 · Dynavax Technologies Corporation · Mar 18, 2026
Publication

Culture Medium For Epithelial Stem Cells And Organoids Comprising Said Stem Cells

EP4253529A2 · Koninklijke Nederlandse Akademie van Wetenschappen · Mar 18, 2026
Publication

Gip/Glp1 Agonist Compositions

EP4257185A2 · Eli Lilly and Company · Mar 18, 2026
Publication

Identification Of Common Tumor Specific T Cell Receptors And Antigens

EP4249592A2 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Topical Compositions And Methods For Treating Inflammatory Skin Diseases

EP4252844A2 · AZORA THERAPEUTICS, INC. · Mar 18, 2026
Publication

Neuroactive Steroids, Compositions, And Uses Thereof

EP4245369A2 · Sage Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Diagnosis, Treatment Of And Prevention Of Kidney Disease

EP4453235A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Activin Actrii Antagonists And Uses For Treating Myelodysplastic Syndrome

EP4233889A2 · Celgene Corporation · Mar 18, 2026
Publication

Pseudotyped Viral Particles, Compositions Comprising The Same, And Uses Thereof

EP4448550A2 · Interius Biotherapeutics, Inc. · Mar 18, 2026
Publication

Therapeutic Single Domain Antibody

EP4392459A2 · Singh Biotechnology, LLC · Mar 18, 2026
Publication

Methods For Making Extracellular Vesicles, And Compositions And Methods Of Use Thereof

EP4419120A2 · Evia Life Sciences Inc. · Mar 18, 2026
Publication

Bcat2 Inhibitors

EP4430036A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Sapovirus Vaccines

EP4362975A2 · VST LLC dba Medgene Labs · Mar 18, 2026
Publication

Inhibitors Of Menin Mll Interaction

EP4444300A2 · Bala Therapeutics, Inc. · Mar 18, 2026
Publication

Bifunctional Chimeric Molecules For Labeling Of Kinases With Target Binding Moieties And Methods Of Use Thereof

EP4433458A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Bisphosphocin Gel Formulations And Uses Thereof

EP4241769A2 · Lakewood Amedex, Inc. · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Biomarkers For Cancer Treatment

EP4291902A2 · Foundation Medicine, Inc. · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

Lymphocytes Expressing Heterologous Targeting Constructs

EP4015525A2 · GammaDelta Therapeutics Limited · Mar 18, 2026
Publication

Immunoassay Of S Adenosylmethionine Using Analogs Thereof And Personalized Therapeutics

EP3915584A2 · Hao, Xiujuan · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Histone Deacytlase 6 Modulation Of Titin Protein Mediated Cardiac Tissue Stiffness And Method For Same

EP4069364A2 · The Regents of the University of Colorado, a body corporate · Mar 18, 2026
Publication

A Method Of Altering A Differentiation Status Of A Cell

EP3953452A2 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Methods For Expansion Of Natural Killer (Nk) Cell Subset And Related Compositions And Methods

EP3884041A2 · Indapta Therapeutics, Inc. · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Hydroxynorketamine For The Use In The Treatment Of Depression

EP3641742A2 · Ketabon GmbH · Mar 18, 2026
Publication

Compositions For Prolonging The Survival After Orthopic And Heteropic Xenogeneic Heart, Kidney, Lung Or Liver Transplantations

EP3773570A2 · Reichart, Bruno · Mar 18, 2026
Publication

C5 Ar Inhibitors For Use In The Treatment Of Chemotherapy Induced Iatrogenic Pain

EP3723744A2 · Dompé farmaceutici S.p.A. · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Compositions And Methods For Treating Pain Disorders

EP3610019A2 · Mansell, John · Mar 18, 2026
Publication

Biologic For The Treatment Of Cancer

EP3606548A2 · Loma Linda University · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Optimised Subcutaneous Therapeutic Agents

EP2838566A2 · Cantab Biopharmaceuticals Patents Limited · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026
Publication

Generation Of Neural Stem Cells From Human Trophoblast Stem Cells

EP2640403A2 · Accelerated BioSciences Corp. · Mar 18, 2026